C. Neil Lyons
Direktor/Vorstandsmitglied bei Panacela Labs, Inc.
Profil
C.
Neil Lyons is currently the Director at Panacela Labs, Inc. He previously worked as the CFO, Treasurer, CAO & Head-Investor Relations at RegeneRx Biopharmaceuticals, Inc. from 2005 to 2011.
He also worked as the Chief Financial Officer at HFS, Inc. and Vice President-Finance at SkyBridge LP.
From 1996 to 1998, he was a Senior Financial Executive at Bell Atlantic Corp.
He received his undergraduate degree from Florida Southern College.
Aktive Positionen von C. Neil Lyons
| Unternehmen | Position | Beginn |
|---|---|---|
Panacela Labs, Inc.
 Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Direktor/Vorstandsmitglied | 01.04.2014 |
Ehemalige bekannte Positionen von C. Neil Lyons
| Unternehmen | Position | Ende |
|---|---|---|
| STATERA BIOPHARMA, INC. | Finanzdirektor/CFO | 06.05.2016 |
| REGENERX BIOPHARMACEUTICALS, INC. | Finanzdirektor/CFO | 31.08.2011 |
| HFS, Inc. | Finanzdirektor/CFO | 20.04.2005 |
| SkyBridge LP | Finanzdirektor/CFO | 01.01.2003 |
| Bell Atlantic Corp. | Corporate Officer/Principal | 01.01.1998 |
Ausbildung von C. Neil Lyons
| Florida Southern College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| HFS, Inc. | Commercial Services |
| Bell Atlantic Corp. | Communications |
| SkyBridge LP | |
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Health Technology |
